INTRODUCTION
A commercial reagent, known as the isobaric tag for relative and absolute quantification (iTRAQ) , makes it possible to analyze multiple samples simultaneously. The ability of iTRAQ to compare relative protein abundances across as many as eight samples is a significant advantage over other stable isotope strategies, such as stable isotope labeling by amino acids in cell culture (SILAC) and isotope-coded affinity tag (ICAT). The iTRAQ protocol set compares the proteome of Saccharomyces cerevisiae under two different metabolic states (fermentation versus respiration) with the goal of determining the proteins involved in each of the activated pathways by measuring their relative abundances using iTRAQ. This protocol describes the preparation of yeast peptides in different metabolic states for iTRAQ analysis.
RELATED INFORMATION
Protocols are available for Labeling Yeast Peptides with the iTRAQ Reagent (Simon 2011a), iTRAQLabeled Yeast Peptide Clean-Up Using a Reversed-Phase Column (Simon 2011b) , and Isoelectric Focusing of iTRAQ-Labeled Yeast (Simon 2011c) . See also Bradford Assay (Harlow and Lane 2006) .
The original iTRAQ reagent can compare up to four samples in parallel (Ross et al. 2004) , whereas a more current version can handle multiplexing of up to eight samples (Choe et al. 2007) . Figure 1 provides a diagram of the workflow that will be followed in the iTRAQ protocols. Briefly:
1. The peptides are labeled with different iTRAQ tags. With four iTRAQ tags (114, 115, 116, and 117) and only two samples, a double duplex experiment can be performed. i. For fermentative growth, cultivate S. cerevisiae wild-type strain BJ1991 on rich YEPD growth medium. Inoculate a cell colony in 50 mL of liquid YEPD growth medium and grow to an optical density (OD) of 1 ( 107 cells). Add 0.1-5 mL (volume depends on calculated doubling time and number of cells desired) of the starter culture to 1 L of liquid YEPD growth medium and grow to an OD of 1. Divide into 50-mL aliquots and pellet the cells by centrifugation (5000 rpm). This yields approximately 0.8-1 g of cells per 50 mL.
ii. For growth under respiration conditions, grow a wild-type starter culture in rich YEPD growth medium to an OD of 1-2 (as described in Step 1i). Add 0.1-5 mL of the starter culture to 1 L of liquid YEPD growth medium and grow to an OD of 1 as described in Step 1i. Pellet the cells (50-mL aliquots) by centrifugation (5000 rpm). Transfer the cells to YPG medium for iTRAQ containing 3% (v/v) glycerol. Collect the cells by centrifugation from 50-mL aliquots (5000 rpm) after 16 h. This yields approximately 0.8-1 g of cells per 50 mL.
The yeast cell pellets from Steps 1 and 2 can be stored frozen at -80˚C. Lysis of Yeast Cell Pellets 2. Allow the yeast cells to thaw, and then add 4 mL of lysis solution for iTRAQ to 0.9 g of yeast cell pellet. Shake the mixture gently for 30 min at room temperature.
3. Remove cell debris by centrifugation at 4˚C.
4. Collect the soluble protein. Using the Bradford method, determine the amount of protein recovered, and store the sample at -80˚C until needed.
Precipitation of Protein
5. Add cold acetone to the protein sample at a 5:1 ratio (acetone/sample, v/v). Incubate it for 2 h at −20˚C.
6. Centrifuge the sample at 12,500g for 5 min at 4˚C.
7. Discard the supernatant. Wash the pellet with cold acetone and centrifuge again.
8. Dry the protein pellet in a vacuum evaporator for 10 min to remove residual acetone.
9. Dissolve the pellet in 60 μL of 7 M urea/500 mM triethylammonium bicarbonate (TEAB).
TEAB is used in place of ammonium bicarbonate because it has no primary amines, which would interfere with iTRAQ labeling.
Reduction, Alkylation, and Digestion of Proteins 10. Add 5 μL of 200 mM DTT to reduce the disulfide bonds. Incubate for 1 h at room temperature.
11. Add 20 μL of 200 mM iodoacetamide (carbamidomethylation). Incubate the reactions for 1 h in the dark at room temperature.
12. Quench the alkylation reaction by adding 20 μL of 200 mM DTT and incubating for 1 h at room temperature.
13. Dilute the protein samples with 500 mM TEAB, so that the urea concentration is <2 M.
14. Add trypsin to a final 1:25 ratio (trypsin/sample). Incubate the mixture overnight at 37˚C.
15.
Store the peptides at -20˚C.
DISCUSSION
The field of proteomics, in its brief history, has progressed rapidly from merely identifying proteins within large, complex mixtures to additionally determining the relative abundance of proteins between two or more samples. This progression to quantitative measurements can be attributed to the advancements made in mass spectrometry (MS) and the adoption of stable isotope labeling strategies for distinguishing the relative abundance of like peptides between samples (Gygi et al. 1999; Ong and Mann 2005) . Typically, a set of reagents consists of one tag that has a natural isotope distribution and a complementary tag consisting of the exact elemental composition and chemical structure, except that it is isotope enriched, typically with 13 C, although 2 H and 15 N can be used as well. The isotope-enriched tag, or heavy reagent, is chemically equivalent to the light reagent but has a higher mass. In a typical workflow, peptides from a control sample are labeled with the light reagent, and an experimental sample is labeled with the heavy reagent. The two labeled peptide samples are then mixed, fractionated, and analyzed by MS. A peptide present in both samples will have essentially the same physicochemical properties, including charge state, isoelectric point, and hydrophobicity, despite having tags of slightly different mass. As a peptide elutes, relative quantification is determined in the MS mode by integrating the peaks under the extracted ion chromatograms of each of the light and heavy labeled peptides across their chromatographic peak (Ong and Mann 2005) . Figure 2 provides an example of this concept. Examples of stable isotope labeling strategies that yield MS-mode quantification in this way are SILAC (Ong et al. 2002) and ICAT (Gygi et al. 1999) .
Despite the effectiveness of these strategies, no more than two or three samples can be compared in one experiment. This is due to the inherent increase in complexity of the spectra in the MS mode when multiple isotope-enriched tags are used. For example, if a control is tagged with a light reagent and the www.cshprotocols.org 114, 115, 116, or 117 Da. The next component of iTRAQ is the mass balancer, a carbonyl group, which is isotope enriched to have an offset mass of 31, 30, 29, or 28 Da, depending on the mass of the reporter group it is paired with. The reporter and mass balancer combine to yield a mass equivalence of 145 Da [(114 + 31) , (115 + 30), (116 + 29), and (117 + 28)] across a set of four isobaric tags. The third component of iTRAQ is an amine-reactive group, N-hydroxysuccinimide, which derivatizes peptides at primary amines, thus targeting the amino termini and lysine side chains. Once the peptides have been derivatized, they are mixed together. A peptide present in all four samples will appear as a single peak in an MS survey scan. However, once fragmented, the peptide's MS/MS spectrum will contain the signature series of reporter peaks at 114-117 Da that are used for quantification. Also present in the MS/MS spectrum are a series of peaks representing amide backbone fragments, like b and y ions, that are used for peptide identification. Figure 4 displays two spectra acquired on a MALDI TOF/TOF mass spectrometer that illustrate these concepts. Figure 4A shows a precursor spectrum of iTRAQ-labeled peptides. Figure 4B shows an MS/MS spectrum of the precursor ion of m/z 1626.0. Each of the iTRAQ tags contains an isotope distribution such that the derivatized peptides are indistinguishable in MS spectra but yield signature ions in the low mass region of MS/MS spectra. The inset (Fig. 4B) shows the region of the MS/MS spectrum that contains the peaks corresponding to the iTRAQ reporter ions. The intensities of the reporter ions reflect the relative abundance of the peptide in each of the samples queried.
